[{"id":"0f907d6a-886a-4312-b378-9b3342ccf9d6","acronym":"","url":"https://clinicaltrials.gov/study/NCT02058680","created_at":"2021-01-18T09:28:23.906Z","updated_at":"2024-07-02T16:37:07.096Z","phase":"Phase 1a/1b","brief_title":"Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients","source_id_and_acronym":"NCT02058680","lead_sponsor":"OncBioMune Pharmaceuticals","biomarkers":" EGFR","pipe":"","alterations":" ","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Prostatac (PSA/IL-2/GM-CSF vaccine)"],"overall_status":"Unknown status","enrollment":" Enrollment 48","initiation":"Initiation: 04/01/2012","start_date":" 04/01/2012","primary_txt":" Primary completion: 12/01/2018","primary_completion_date":" 12/01/2018","study_txt":" Completion: 12/01/2018","study_completion_date":" 12/01/2018","last_update_posted":"2018-09-10"}]